No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe

por Stieler, Kristin, Schindler, Sarah, Schlomm, Thorsten, Hohn, Oliver, Bannert, Norbert, Simon, Ronald, Minner, Sarah, Schindler, Michael, Fischer, Nicole
Publicado 2011

IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues

por Burdelski, Christoph, Jakani-Karimi, Nilofar, Jacobsen, Frank, Möller-Koop, Christina, Minner, Sarah, Simon, Ronald, Sauter, Guido, Steurer, Stefan, Clauditz, Till S., Wilczak, Waldemar
Publicado 2018

VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in Prostate Cancer

por Poulose, Ninu, Forsythe, Nicholas, Polonski, Adam, Gregg, Gemma, Maguire, Sarah, Fuchs, Marc, Minner, Sarah, Sauter, Guido, McDade, Simon S., Mills, Ian G.
Publicado 2022

Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer

por Hennigs, Jan K., Minner, Sarah, Tennstedt, Pierre, Löser, Rolf, Huland, Hartwig, Klose, Hans, Graefen, Markus, Schlomm, Thorsten, Sauter, Guido, Bokemeyer, Carsten, Honecker, Friedemann
Publicado 2020

High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer

por JACOBSEN, FRANK, ASHTIANI, SHARAD NOURAIE, TENNSTEDT, PIERRE, HEINZER, HANS, SIMON, RONALD, SAUTER, GUIDO, SIRMA, HÜSEYIN, TSOURLAKIS, MARIA CHRISTINA, MINNER, SARAH, SCHLOMM, THORSTEN, MICHL, UWE
Publicado 2013

Loss of Somatostatin Receptor Subtype 2 in Prostate Cancer Is Linked to an Aggressive Cancer Phenotype, High Tumor Cell Proliferation and Predicts Early Metastatic and Biochemical...

por Hennigs, Jan K., Müller, Julia, Adam, Matti, Spin, Joshua M., Riedel, Emilia, Graefen, Markus, Bokemeyer, Carsten, Sauter, Guido, Huland, Hartwig, Schlomm, Thorsten, Minner, Sarah
Publicado 2014

Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer

por Burdelski, Christoph, Matuszewska, Aleksandra, Kluth, Martina, Koop, Christina, Grupp, Katharina, Steurer, Stefan, Wittmer, Corinna, Minner, Sarah, Tsourlakis, Maria Christina, Sauter, Guido, Schlomm, Thorsten, Simon, Ronald
Publicado 2014

Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

por SIRMA, HÜSEYIN, BROEMEL, MARGARETHE, STUMM, LAURA, TSOURLAKIS, TINA, STEURER, STEFAN, TENNSTEDT, PIERRE, SALOMON, GEORG, MICHL, UWE, HAESE, ALEXANDER, SIMON, RONALD, SAUTER, GUIDO, SCHLOMM, THORSTEN, MINNER, SARAH
Publicado 2013

Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer

por Kluth, Martina, Meyer, David, Krohn, Antje, Freudenthaler, Fabian, Bauer, Melanie, Salomon, Georg, Heinzer, Hans, Michl, Uwe, Steurer, Stefan, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten, Minner, Sarah
Publicado 2015

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients

por Tsourlakis, Maria-Christina, Stender, Annegret, Quaas, Alexander, Kluth, Martina, Wittmer, Corinna, Haese, Alexander, Graefen, Markus, Steurer, Stefan, Simon, Ronald, Korbel, Jan, Weischenfeldt, Joachim, Huland, Hartwig, Sauter, Guido, Schlomm, Thorsten, Minner, Sarah
Publicado 2016

High mitochondria content is associated with prostate cancer disease progression

por Grupp, Katharina, Jedrzejewska, Karolina, Tsourlakis, Maria Christina, Koop, Christina, Wilczak, Waldemar, Adam, Meike, Quaas, Alexander, Sauter, Guido, Simon, Ronald, Izbicki, Jakob Robert, Graefen, Markus, Huland, Hartwig, Schlomm, Thorsten, Minner, Sarah, Steurer, Stefan
Publicado 2013

Random forest-based modelling to detect biomarkers for prostate cancer progression

por Toth, Reka, Schiffmann, Heiko, Hube-Magg, Claudia, Büscheck, Franziska, Höflmayer, Doris, Weidemann, Sören, Lebok, Patrick, Fraune, Christoph, Minner, Sarah, Schlomm, Thorsten, Sauter, Guido, Plass, Christoph, Assenov, Yassen, Simon, Ronald, Meiners, Jan, Gerhäuser, Clarissa
Publicado 2019

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

por Burdelski, Christoph, Menan, Devi, Tsourlakis, Maria Christina, Kluth, Martina, Hube-Magg, Claudia, Melling, Nathaniel, Minner, Sarah, Koop, Christina, Graefen, Markus, Heinzer, Hans, Wittmer, Corinna, Sauter, Guido, Simon, Ronald, Schlomm, Thorsten, Steurer, Stefan, Krech, Till
Publicado 2015

Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy

por Soave, Armin, Kluwe, Lan, Yu, Hang, Rink, Michael, Gild, Philipp, Vetterlein, Malte W., Marks, Philipp, Sauter, Guido, Fisch, Margit, Meyer, Christian P., Ludwig, Tim, Dahlem, Roland, Minner, Sarah, Pantel, Klaus, Steinbach, Bettina, Schwarzenbach, Heidi
Publicado 2020

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

por Schroeder, Cornelia, Grell, Jan, Hube-Magg, Claudia, Kluth, Martina, Lang, Dagmar, Simon, Ronald, Höflmayer, Doris, Minner, Sarah, Burandt, Eike, Clauditz, Till S., Büscheck, Franziska, Jacobsen, Frank, Huland, Hartwig, Graefen, Markus, Schlomm, Thorsten, Sauter, Guido, Steurer, Stefan
Publicado 2019

VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy

por Tsourlakis, Maria Christina, Khosrawi, Puya, Weigand, Philipp, Kluth, Martina, Hube-Magg, Claudia, Minner, Sarah, Koop, Christina, Graefen, Markus, Heinzer, Hans, Wittmer, Corinna, Sauter, Guido, Krech, Till, Wilczak, Waldemar, Huland, Hartwig, Simon, Ronald, Schlomm, Thorsten, Steurer, Stefan
Publicado 2015

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

por Zabalza, Cristina Villares, Adam, Meike, Burdelski, Christoph, Wilczak, Waldemar, Wittmer, Corina, Kraft, Stefan, Krech, Till, Steurer, Stefan, Koop, Christina, Hube-Magg, Claudia, Graefen, Markus, Heinzer, Hans, Minner, Sarah, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten, Tsourlakis, Maria Christina
Publicado 2015

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

por Burdelski, Christoph, Bujupi, Erzen, Tsourlakis, Maria Christina, Hube-Magg, Claudia, Kluth, Martina, Melling, Nathaniel, Lebok, Patrick, Minner, Sarah, Koop, Christina, Graefen, Markus, Heinzer, Hans, Wittmer, Corinna, Sauter, Guido, Wilczak, Waldemar, Simon, Ronald, Schlomm, Thorsten, Steurer, Stefan, Krech, Till
Publicado 2015

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

por Burdelski, Christoph, Strauss, Christian, Tsourlakis, Maria Christina, Kluth, Martina, Hube-Magg, Claudia, Melling, Nathaniel, Lebok, Patrick, Minner, Sarah, Koop, Christina, Graefen, Markus, Heinzer, Hans, Wittmer, Corinna, Krech, Till, Sauter, Guido, Wilczak, Waldemar, Simon, Ronald, Schlomm, Thorsten, Steurer, Stefan
Publicado 2015

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

por Melling, Nathaniel, Harutyunyan, Levon, Hube-Magg, Claudia, Kluth, Martina, Simon, Ronald, Lebok, Patrick, Minner, Sarah, Tsourlakis, Maria Christina, Koop, Christina, Graefen, Markus, Adam, Meike, Haese, Alexander, Wittmer, Corinna, Steurer, Stefan, Izbicki, Jakob, Sauter, Guido, Wilczak, Waldemar, Schlomm, Thorsten, Krech, Till
Publicado 2015